Is Crizotinib produced in China? How much does it cost?
Crizotinib (Crizotinib), as a targeted therapy drug, is different from traditional chemotherapy in that it can more selectively target specific molecular targets in cancer cells, thereby reducing damage to normal cells to a certain extent. Because crizotinib targets specific gene abnormalities, it is only suitable for patients with ALK positive NSCLC and ROS1 NSCLC and may not have the same therapeutic effect on other types of cancer. Before using crizotinib, doctors usually perform genetic testing on patients to determine whether they are positive for ALK or ROS1 fusions to determine whether they are suitable for treatment with the drug.

Crizotinib is currently on the market in China and is included in medical insurance. Patients can purchase it domestically, and the price is around 6,000~12,000 yuan. Since the price of medical insurance policies varies greatly across regions, please consult your local pharmacy or medical insurance bureau for specific prices. There are original and generic versions of crizotinib available abroad. The original version is mainly Pfizer’s original drug, and the price is around 11,000 yuan. Generic drugs are mainly from Bangladesh and Laos. Due to different pharmaceutical manufacturers and drug specifications, generic drugs cost around 2,700~3,000 yuan. Moreover, the ingredients of foreign original drugs and generic drugs are basically the same as those of domestic drugs.
Crizotinib is a targeted therapy drug used to treat certain types of cancer. It is mainly used to treat tyrosine kinase fusion-positive non-small cell lung cancer (NSCLC) and ROS1 fusion-positive non-small cell lung cancer. ALKfusion-positiveNSCLC is a specific subtype of NSCLC. In this tumor type, the cancer cells have an abnormality called an ALK fusion gene, which causes the ALK protein to fuse with other proteins and cause the cells to produce abnormal growth and proliferation signals. As a targeted therapy drug, crizotinib can inhibit abnormal ALK protein, thereby slowing the growth and spread of tumors and prolonging the survival of patients.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)